Results 101 to 110 of about 9,301 (205)
No Residual Activity of Raltegravir After Development of 148 Complex Mutations In Vivo [PDF]
, 2008 Homayoon Khanlou +2 more
openalex +1 more source
Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir [PDF]
, 2009 William D. Hanley +9 more
openalex +1 more source
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors [PDF]
, 2009 Erik Serrao +3 more
openalex +1 more source
Are new antiretroviral treatments increasing the risks of clinical obesity?
Journal of Virus Eradication, 2019 There is growing evidence that the use of integrase inhibitors could lead to statistically significant increases in body weight and even clinical obesity, although it is unclear whether these changes are clinically significant.
Andrew Hill, Laura Waters, Anton Pozniak
doaj
Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life [PDF]
, 2009 Philip Grant +8 more
openalex +1 more source
Качественная клиническая практика, 2018 Objective: To perform comprehensive pharmacoeconomical assessment of use etravirine and raltegravir in HIV-infected patients. Methodology: Cost-eifectiveness and budget impact analyses of etravirine or raltegravir on the top of optimized background ...
Y. I. Ashikhmin, D. Yu. Belousov
doaj
Informe técnico raltegravir 400mg tableta
, 2011 Basado en la revisión y análisis de la evidencia científica respecto al medicamento Raltegravir 400mg tableta, el Equipo Técnico acuerda no incluirlo al Petitorio Nacional Único de Medicamentos Esenciales (PNUME), debido a que su uso es altamente especializado y es considerado como parte de los esquemas de tercera línea en el manejo de la infección por
openaire +6 more sources